Curis Inc (CRIS)
14.35
-0.59
(-3.95%)
USD |
NASDAQ |
Apr 19, 16:00
14.35
0.00 (0.00%)
After-Hours: 19:08
Curis Cash from Operations (TTM): -38.43M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -38.43M |
| September 30, 2023 | -40.52M |
| June 30, 2023 | -45.46M |
| March 31, 2023 | -49.72M |
| December 31, 2022 | -54.34M |
| September 30, 2022 | -50.24M |
| June 30, 2022 | -46.73M |
| March 31, 2022 | -41.26M |
| December 31, 2021 | -37.62M |
| September 30, 2021 | -35.16M |
| June 30, 2021 | -31.43M |
| March 31, 2021 | -29.90M |
| December 31, 2020 | -25.74M |
| September 30, 2020 | -25.62M |
| June 30, 2020 | -26.45M |
| March 31, 2020 | -27.99M |
| December 31, 2019 | -26.20M |
| September 30, 2019 | -25.55M |
| June 30, 2019 | -27.06M |
| March 31, 2019 | -27.33M |
| December 31, 2018 | -30.06M |
| September 30, 2018 | -32.63M |
| June 30, 2018 | -40.89M |
| March 31, 2018 | -43.17M |
| December 31, 2017 | -48.36M |
| Date | Value |
|---|---|
| September 30, 2017 | -50.24M |
| June 30, 2017 | -41.34M |
| March 31, 2017 | -42.97M |
| December 31, 2016 | -35.81M |
| September 30, 2016 | -37.29M |
| June 30, 2016 | -34.19M |
| March 31, 2016 | -30.12M |
| December 31, 2015 | -29.89M |
| September 30, 2015 | -23.72M |
| June 30, 2015 | -21.32M |
| March 31, 2015 | -19.27M |
| December 31, 2014 | -16.81M |
| September 30, 2014 | -17.63M |
| June 30, 2014 | -15.27M |
| March 31, 2014 | -10.52M |
| December 31, 2013 | -9.540M |
| September 30, 2013 | -17.37M |
| June 30, 2013 | -21.82M |
| March 31, 2013 | -23.46M |
| December 31, 2012 | -15.19M |
| September 30, 2012 | 6.833M |
| June 30, 2012 | 6.589M |
| March 31, 2012 | 4.003M |
| December 31, 2011 | -4.563M |
| September 30, 2011 | -16.97M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-54.34M
Minimum
Dec 2022
-25.55M
Maximum
Sep 2019
-36.07M
Average
-35.16M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Kura Oncology Inc | -124.82M |
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Armata Pharmaceuticals Inc | -47.42M |